PeerVoice Oncology & Haematology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 230 Folge(n) erschienen. Jede Woche gibt es eine neue Folge dieses Podcasts.

Gesamtlänge aller Episoden: 3 days 21 hours 5 minutes

subscribe
share





Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies


Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies


share







   1h0m
 
 

Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?


Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?


share







   19m
 
 

Optimising Outcomes With PARPs in Advanced Ovarian Cancer


Optimising Outcomes With PARPs in Advanced Ovarian Cancer


share







   12m
 
 

Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses


Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses


share







 2021-10-27  5m
 
 

Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them


Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them


share







 2021-10-22  24m
 
 

The Need for Speed: Improving Diagnostic Accuracy and Effective Management of aTTP in Emergency and Intensive Care


The Need for Speed: Improving Diagnostic Accuracy and Effective Management of aTTP in Emergency and Intensive Care


share







 2021-10-22  1h21m
 
 

The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal


The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal


share







 2021-10-22  19m
 
 

Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action


Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action


share







 2021-09-22  20m
 
 

Improving Outcomes in Non-Metastatic CRPC: Case by Case


Improving Outcomes in Non-Metastatic CRPC: Case by Case


share







 2021-08-19  20m
 
 

An Immune System in Double Trouble: What Is ‘Best Practice’ for Managing Patients With Lymphoproliferative Malignancies?


An Immune System in Double Trouble: What Is ‘Best Practice’ for Managing Patients With Lymphoproliferative Malignancies?


share







 2021-08-13  41m